-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk: Novo Nordisk's real-world study showed that in adult patients with metabolism-related steatohepatitis, the use of 2.4 mg of Wegovy was associated with lower liver enzymes, body weight, and blood sugar.

Zhitongcaijing·11/06/2026 20:09:02
Listen to the news
Novo Nordisk: Novo Nordisk's real-world study showed that in adult patients with metabolism-related steatohepatitis, the use of 2.4 mg of Wegovy was associated with lower liver enzymes, body weight, and blood sugar.